pharma

NY Times Touts New FDA Regulations, Ignores Industry

admin — Thu, 24 Jan 2008 22:19:46 +0000

Nathan Burchfiel

Prescription drugs are more expensive in the United States than other countries for a number of reasons, arguably the biggest of which is that other governments artificially control prices so that Americans are left with the burden of funding research and development of new drugs.

CBS Reporter Says Massive FDA Expansion Will 'Fix' Everything

admin — Thu, 20 Sep 2007 21:07:50 +0000

Stuart James

As Congress considers a bill giving the Food and Drug Administration even more power – including charging drug companies five times as much for safety reviews – CBS News applauded the move.

Networks Dramatize Diabetes Drug Dangers

admin — Tue, 22 May 2007 18:15:21 +0000

Jeff Poor

“We’re starting with a story that affects hundreds of thousands of Americans because a new study out today says a drug they take increases their chances of having a heart attack and dying,” said anchor Katie Couric on the “CBS Evening News.”

“Some doctors warn this could become one of the country’s biggest drug catastrophes in recent memory,” said John McKenzie, ABC’s medical science correspondent on “World News.”

ABC and CBS Give No Credit to Novartis

admin — Thu, 03 May 2007 19:29:00 +0000

Julia A. Seymour

Both ABC and CBS evening news programs praised a new drug that could save lives threatened by osteoporosis. But they didn’t say what company spent years and millions of dollars developing it.

ABC “World News” anchor Charles Gibson called it “promising news.”

“CBS Evening News” anchor Katie Couric agreed, saying the new drug “may be just what the doctor ordered” for the 10 million Americans living with the disease.

Student Loan Providers 'Sound Like Drug Companies,' CNN Reporter Scolds

admin — Mon, 16 Apr 2007 17:43:10 +0000

Amy Menefee

Rachel Waters

Guilty until proven innocent – that was the verdict for the student loan industry on CNN’s “In the Money.”

The show’s anchors turned a story on investigation of college financial aid offices into a diatribe on corporate scandal and an approval of more government control of student borrowing.

“This kind of a scandal is the kind of thing you think about when you think about Enron and, y’know, Wall Street firms and chop shops …” said panelist Jennifer Westhoven on the April 14 program.

CBS Reporter Takes Swipe at Drug Industry, Praises Politician in Blog Post

admin — Fri, 15 Dec 2006 15:18:04 +0000

Ken Shepherd

“What can be done to break Big Pharma’s growing control of our minds and bodies? I wish I knew,” a critic of the pharmaceutical industry wrote recently on a media blog. But the author of that post was an ostensibly unbiased investigative journalist: CBS correspondent Armen Keteyian.

Network blogs can be a valuable, unfiltered look at reporters’ biases, and Keteyian’s December 14 post to CBS’s “Primary Source” was no exception.